1
Mevissen, M. R. J., Geurten, Rose Julie, Hendriks, S. H., Elissen, Arianne, van Dijk, Peter Ruben, Bilo, Henk J. G.
Veröffentlicht in: Mevissen , M R J , Geurten , R J , Hendriks , S H , Elissen , A , van Dijk , P R & Bilo , H J G 2022 , ' Distribution of care expenditures for men and women with type 2 diabetes treated in primary care in the Netherlands : a case-control study (ZODIAC-59) ' , BMJ Open , vol. 12 , no. 2 , 052592 . https://doi.org/10.1136/bmjopen-2021-052592;
2022
Veröffentlicht in: Mevissen , M R J , Geurten , R J , Hendriks , S H , Elissen , A , van Dijk , P R & Bilo , H J G 2022 , ' Distribution of care expenditures for men and women with type 2 diabetes treated in primary care in the Netherlands : a case-control study (ZODIAC-59) ' , BMJ Open , vol. 12 , no. 2 , 052592 . https://doi.org/10.1136/bmjopen-2021-052592;
2022
2
Bos, J.M., Rietveld, E., Moll, HA, Steyerberg, E.W., Luytjes, W., Wilschut, J.C., de Groot, R., Postma, M.J.
Veröffentlicht in: Bos , J M , Rietveld , E , Moll , HA , Steyerberg , E W , Luytjes , W , Wilschut , J C , de Groot , R & Postma , M J 2007 , ' The use of health economics to guide drug development decisions : Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach ' , Vaccine , vol. 25 , no. 39-40 , pp. 6922-6929 . https://doi.org/10.1016/j.vaccine.2007.07.006;
2007
Veröffentlicht in: Bos , J M , Rietveld , E , Moll , HA , Steyerberg , E W , Luytjes , W , Wilschut , J C , de Groot , R & Postma , M J 2007 , ' The use of health economics to guide drug development decisions : Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach ' , Vaccine , vol. 25 , no. 39-40 , pp. 6922-6929 . https://doi.org/10.1016/j.vaccine.2007.07.006;
2007